A Medicine study used artificial intelligence to discover a naturally occurring molecule, specifically, a peptide, that ...
MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...
2d
Investor's Business Daily on MSNNovo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1Novo Nordisk stock slipped 1.2% to 69.30. Novo Nordisk Is On A Licensing Spree. This is the second big weight-loss deal from Novo ...
A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those ...
With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply for ...
5d
Pharmaceutical Technology on MSNNovo Nordisk earmarks $2bn for Chinese “triple G” weight loss shotNovo Nordisk has acquired the global rights to China-based United Laboratories’ triple-agonist weight-loss and diabetes drug ...
Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...
It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...
Roxy Jacenko continued her rigorous health kick on Monday as she was spotted enjoying a green juice with friends in ritzy ...
Biologists have discovered that bombesin, a neurohormone controlling appetite in humans, also regulates feeding in starfish, revealing its ancient evolutionary origin dating back over 500 million ...
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
For Nutrition Awareness Month, we highlight the importance of tailoring dietary strategies to patients with cancer to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results